News

Filter

Current filters:

None

1 to 9 of 97216 results

FDA approves new antibacterial drug Zerbaxa

20-12-2014

The US Food and Drug Administration has approved Cubist Pharmaceuticals’Zerbaxa (ceftolozane/tazobactam)…

Antibiotics and Infectious diseasesCubist PharmaceuticalsMerck & CoPharmaceuticalRegulationUSAZerbaxa

Bina Technologies is acquired by Roche

20-12-2014

Swiss pharma giant Roche has acquired Bina Technologies, a privately held company based in Redwood City,…

Bina TechnologiesBiotechnologyMergers & AcquisitionsRoche

RXi and Hapten enter into licensing agreement for Samcyprone

RXi and Hapten enter into licensing agreement for Samcyprone

19-12-2014

RNA technology specialist RXi Pharmaceuticals Corp has entered into a global licensing agreement with…

BiotechnologyDermatologicalsLicensingNeurologicalRXi Pharmaceuticals

Cuba a huge opportunity for life sciences, says Abivax

Cuba a huge opportunity for life sciences, says Abivax

19-12-2014

Paris-based antiviral specialist Abivax has spoken in praise of the decision between the USA and Cuba…

ABIVAXABIVAXCubaPharmaceuticalUnited States

UPDATE: Lilly rekindles deal with Adocia to develop ultra rapid insulin

UPDATE: Lilly rekindles deal with Adocia to develop ultra rapid insulin

19-12-2014

US pharma major Eli Lilly and French biotech firm Adocia have entered into a worldwide licensing collaboration…

AdociaBioChaperone LisproBiotechnologyDiabetesEli LillyGlobalLicensing

Pfizer touts strong Ph III results for Lyrica CR for postherpetic neuralgia

Pfizer touts strong Ph III results for Lyrica CR for postherpetic neuralgia

19-12-2014

US pharma giant Pfizer has released top-line results from a double-blind Phase III study evaluating pregabalin…

LyricaNeurologicalPfizerPharmaceuticalPregabalinResearchUSA

1 to 9 of 97216 results

Back to top